Burning Rock Biotech (BNR) Inventory (2019 - 2026)

Burning Rock Biotech (BNR) has reported Inventory for 8 consecutive years, with $7.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory fell 12.7% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $7.9 million (down 12.7% YoY), while the FY2025 annual figure was $6.9 million, down 19.04% from the prior year.
• Inventory came in at $7.9 million for Q1 2026 at Burning Rock Biotech, down from $8.0 million in the prior quarter.
• The five-year high for Inventory was $21.1 million in Q3 2022, with the low at $7.5 million in Q4 2024.
• Average Inventory over 5 years is $12.2 million, with a median of $9.5 million recorded in 2024.
• Across the five-year window, Inventory soared 37.63% in 2022 and sank 47.69% in 2023, its largest moves.
• Year by year, Inventory stood at $18.3 million in 2022, then sank by 47.69% to $9.6 million in 2023, then decreased by 21.92% to $7.5 million in 2024, then gained by 7.33% to $8.0 million in 2025, then declined by 2.02% to $7.9 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $7.9 million, $8.0 million, and $7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.